serious-mental-illness

Documents about serious-mental-illness

• Thinking Skills at Work: Cognitive Remediation Therapy for Patients With Serious Mental Illness#873427ClinicalTrials.gov
• White matter microstructure predicts cognitive training-induced improvements in attention and executive functioning in schizophrenia#614730eScholarship
• Effectiveness of a Mobile Texting Intervention for People With Serious Mental Illness#849091ClinicalTrials.gov
• Intervention-specific patterns of cortical function plasticity during auditory encoding in people with schizophrenia#620068eScholarship
• Determinants of patient satisfaction in clozapine users: results from the Clozapine International Consortium (CLOZIN).#682934Apollo
• 12-step Facilitation for the Dually Diagnosed#827102ClinicalTrials.gov
• Facilitation to Increase Tobacco Treatment#892425ClinicalTrials.gov
• Hospital and Skilled Nursing Facility Networks: Informal Relationships and Their Role in the Placement of Traditional Medicare Beneficiaries With Serious Mental Illness.#421157NCBI PubMed Central
• SHARED DECISION-MAKING WITH PEOPLE WITH SERIOUS MENTAL ILLNESS#448634Figshare
• Supporting continuous glucose monitoring for people with serious mental illness and type 2 diabetes: a co-design study for a structured intervention.#653264NCBI PubMed Central
• Getting Out of the House: Using Behavioral Activation to Increase Community Participation#905966ClinicalTrials.gov
• ASSESSMENT OF THE SYNERGISTIC EFFECTS OF STIGMATIZED PATIENT SOCIAL CATEGORIES ON HEALTHCARE PROVIDER TREATMENT CHOICES#462360RUcore, Rutgers University Community Repository
• Mitochondrial Mutations and Polymorphisms in Psychiatric Disorders#612251eScholarship
• Effects of P50 temporal variability on sensory gating in schizophrenia#612248eScholarship
• HIV-Infected Individuals with Co-occurring Bipolar Disorder Evidence Poor Antiretroviral and Psychiatric Medication Adherence#675830eScholarship
• Ecological assessment of transdiagnostic clinical symptoms in serious mental illness with daily smartphone surveys#485075Europe PMC
• In-person vs. Remote Wellness Support#907675ClinicalTrials.gov
• Web-Based Delivery of MOVE! to Veterans With Serious Mental Illness (SMI)#906367ClinicalTrials.gov
• Effect of ancestry and shared genetic architecture of serious mental illness on symptoms and cognition in an admixed Latin American population#261185bioRxiv / medRxiv
• Comparative Effectiveness and Implementation of Best Practices to Prevent COVID-19 in Staff and People With Serious Mental Illness and Developmental Disabilities in Congregate Living Settings: “In This Together”#636136NCBI Bookshelf
• A Novel Peer-Delivered Recovery-Focused Suicide Prevention Intervention for Veterans With Serious Mental Illness#858712ClinicalTrials.gov
• Evaluation of A Statewide Program to Prevent Early Mortality and to Promote Fitness in Persons With SMI#902191ClinicalTrials.gov
• Feasibility and preliminary effectiveness of the Individual Placement and Support (IPS) model for people with serious mental illness in Jalisco, Mexico: a pilot study protocol.#239946NCBI PubMed Central
• Pooled prevalence, risk factors and barriers to care for hepatitis C virus (HCV) in adults with serious mental illness (SMI): an updated systematic review and meta-analysis - protocol.#670915NCBI PubMed Central
• “Someone catching me when I’m falling”: a qualitative study exploring satisfaction in romantic relationships where one partner has borderline personality disorder#414774Figshare
• Use of a Rapid Qualitative Method to Inform the Development of a Text Messaging Intervention for People With Serious Mental Illness Who Smoke: Formative Research Study#311326DigitalCommons@Providence
• Injectable Naltrexone Treatment of Alcohol Dependence in Serious Mental Illness (SMI)#891997ClinicalTrials.gov
• Enhancing Veteran-Clinical Collaboration in VA PRRCs#909076ClinicalTrials.gov
• Persistent CSF but not plasma HIV RNA is associated with increased risk of new-onset moderate-to-severe depressive symptoms; a prospective cohort study#612097eScholarship
• A Pilot Randomized Controlled Trial of the Hopeful and Healthy Living Program#885726ClinicalTrials.gov
• Development of a Mobile System for Self-management of Schizophrenia (SOS)#898731ClinicalTrials.gov
• HEPATITIS C POINT-OF-CARE TESTING AND TREATMENT IN PEOPLE WITH SERIOUS MENTAL ILLNESS: A COHORT STUDY OF COMMUNITY OUTPATIENTS (REACH OUT)#422571Figshare
• Reduction of Anticholinergic Medications Among Persons With Schizophrenia or Other Psychiatric Disorders#877310ClinicalTrials.gov
• Multisystem resiliency moderates the major depression–Telomere length association: Findings from the Heart and Soul Study#642244eScholarship
• The Impact of Substance Abuse Problems and Serious Mental Illness/Serious Emotional Distress on Post-Discharge Residential Status Among Clients with Behavioral and Cognitive Disorders: Evidence from SAMHSA MH-CLD Data#186305ODU Digital Commons
• The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data#629316eScholarship
• Impact of the COVID-19 pandemic on antipsychotic prescribing in individuals with autism, dementia, learning disability, serious mental illness or living in a care home: a federated analysis of 59 million patients’ primary care records in situ using OpenSAFELY#242870Ora Oxford University Research
• PACT for Individuals With Serious Mental Illness#840314ClinicalTrials.gov
• A coach-supported, digital parenting programme for parents of adolescents at risk of suicide: pilot trial of acceptability, feasibility, validity and short-term effects#243685Figshare
• Trends in major depressive episodes and mental health treatment among older adults in the United States, 2010–2019#784271eScholarship
• Understanding suicide risk among LGBTQ+ youth in Peru: Findings from a nationwide mental health survey#612156eScholarship
• Self versus informant reports on the specific levels of functioning scale: Relationships to depression and cognition in schizophrenia and schizoaffective disorder#614753eScholarship
• Suicide risk and prevalence of major depressive disorder (MDD) among individuals infected with HIV-1 subtype C versus B in Southern Brazil#612041eScholarship
• R v Mucpa#638590CanLII